Consistent with our previous observations using low doses of a gnetin C-supplemented diet in a high-risk PIN model of prostate cancer [13], our current study demonstrated that gnetin C was able to reduce the levels of IL-2 compared to the vehicle. The gene discussed is IL2; the disease is Familial prostate cancer.